The USC Marshall School of Business is launching the Renaud Family Business of Healthcare Innovation Program, a new initiative to harness the power of business acumen and cutting-edge technology such as artificial intelligence to accelerate bold new solutions in the rapidly evolving healthcare industry.

The Renaud Program will establish a vibrant hub for interaction and partnership among researchers, teachers and students on campus and with innovators in the private sector across the world. Funding will support the development of: cutting-edge courses, new academic pathways, and joint learning opportunities across USC; research, thought leadership, and academia-meets-industry partnerships; and new incubation and innovation initiatives.

“This generous gift will allow USC to reimagine the future of healthcare through AI and cross-disciplinary collaboration,” USC Interim President Beong-Soo Kim said. “By combining USC’s strengths in business and medicine with our strategic industry partnerships, we can help accelerate the pace of innovation and deliver life-saving treatments to patients faster.”

The program will develop future leaders at the intersection of business, technological change, healthcare innovation, and public policy to enhance the quality of life for people globally. At the center of USC, Marshall is uniquely positioned to launch such an ambitious program and deliver transformational outcomes by bringing together the unparalleled expertise, breadth of intellectual inquiry, and culture of innovation across USC’s 23 schools, including the fields of computing, health, medicine, and business.

“As we enter a golden age of discovery, we’re seeing almost daily advances in medical technology, drug discovery, and our understanding of concepts like aging, obesity and numerous other biological processes,” said Ron Renaud. “I am certain that this program will empower students, researchers, and industry to rise to the occasion and take full advantage of this unprecedented growth, ultimately improving quality of life and lifespan globally for all humans.”

The Renauds are deeply engaged leaders who exemplify the generous spirit of the Trojan Family. Ron is president and CEO of Kailera Therapeutics and graduated from USC Marshall with a Master of Science in Business Administration in 1999. Marianne serves on the Steering Committee and helped to launch the Marshall Torch Initiative for Women’s Philanthropy through the creation of the Renaud Family Endowed Scholarship Fund.